NCT04696055
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04696055
Title Pilot Study of Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ISR | FRA | ESP | DEU

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
City of Hope - Duarte Cancer Center Duarte California 91010 United States Details
USC Norris Hospital and Clinics Los Angeles California 90033 United States Details
University of California Irvine Medical Center Orange California 92868-3201 United States Details
Medical Oncology Hematology Consultants, PA Newark Delaware 19713 United States Details
University of Miami Miller School of Medicine Miami Florida 33136 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Massachusetts General Hospital Boston Massachusetts 02114-2696 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109-1023 United States Details
Hôpital Beaujon - Clichy Clichy 92110 France Details
Center Hospitalier Michallon - Grenoble Grenoble 38043 France Details
Hopital Claude Huriez - Lille Lille 59037 France Details
Hôpital de la Croix Rousse Lyon 69004 France Details
AP-HM - Hopital de la Timone Marseille 13005 France Details
Hôpital Saint-Eloi Montpellier 34059 France Details
Centre François Magendie - Pessac Pessac 33600 France Details
Centre Hospitalier Universitaire de Nancy Vandœuvre-lès-Nancy 54500 France Details
Hôpital Paul Brousse - Villejuif Villejuif 94800 France Details
Eberhard-Karls-Universität Tübingen Tübingen Baden-Wurttemberg 72076 Germany Details
Klinikum der Universität München Grosshadern München Bavaria 81377 Germany Details
Universitätsklinikum Köln Cologne North Rhine-Westphalia 50937 Germany Details
Heinrich-Heine-Universität Düsseldorf Düsseldorf North Rhine-Westphalia 40225 Germany Details
Universitätsmedizin der Johannes Gutenberg Universität Mainz Mainz Rhineland-Palatinate 55101 Germany Details
Rambam Health Corporation Haifa 3109601 Israel Details
Rabin Medical Center | Beilinson Hospital - Internal Medicine C Department Petah Tikva 4941492 Israel Details
Tel-Aviv Sourasky Medical Center Tel Aviv 6423906 Israel Details
Humanitas Mirasole S.p.A. Milan Lombardy 20089 Italy Details
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Lombardy 20122 Italy Details
Azienda Ospedaliero Universitaria Pisana_Santa Chiara - UO Oncologia 2 Pisa Tuscany 56126 Italy Details
Istituto Oncologico Veneto_Padova - UOC Oncologia 1 Padua Veneto 35128 Italy Details
Chiba University Hospital Chiba Chiba 260-8677 Japan Details
National Cancer Center Hospital East Kashiwa Chiba 277-8577 Japan Details
Japanese Red Cross Society Musashino Red Cross Hospital Musashino Tokyo 180-8610 Japan Details
Asan Medical Center Seoul Seoul Teugbyeolsi 05505 South Korea Details
Seoul National University Hospital Seoul Seoul Teugbyeolsi 3080 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Institut Català d'Oncologia Hospitalet L'Hospitalet de Llobregat Barcelona 08907 Spain Details
Hospital Clínic i Provincial de Barcelona Barcelona 8036 Spain Details
Hospital General Universitario Gregorio Marañón | Digestivo Madrid 28007 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field